Open Access<p>MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells</p>
Author(s) -
Bei Zhu,
Weixian Chen,
Yue Fu,
Xiaoping Chen,
Lei Jin,
Jiadeng Chao,
Yun Xiao,
Peng Gao,
Shiting Shan,
Jun Li,
Xinhua Yin,
Chunfu Zhu,
Xihu Qin
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s256153
Subject(s) - pi3k/akt/mtor pathway , flow cytometry , protein kinase b , apoptosis , microrna , cancer research , microbiology and biotechnology , chemistry , cell culture , cell growth , mcf 7 , western blot , breast cancer , cancer , biology , medicine , gene , biochemistry , human breast , genetics
This study aimed to explore the regulative mechanisms of miR-27a-3p in chemo-resistance of breast cancer cells.